Akari Therapeutics PLC (AKTX)
1.16
-0.08
(-6.45%)
USD |
NASDAQ |
Nov 22, 12:17
Akari Therapeutics Shareholders Equity (Quarterly): -6.694M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -6.694M |
| June 30, 2024 | -3.703M |
| March 31, 2024 | -3.553M |
| December 31, 2023 | -0.229M |
| June 30, 2023 | 2.782M |
| June 30, 2022 | 8.326M |
| March 31, 2022 | 13.93M |
| December 31, 2021 | 5.555M |
| September 30, 2021 | 11.36M |
| June 30, 2021 | 1.588M |
| March 31, 2021 | 3.937M |
| December 31, 2020 | 9.384M |
| September 30, 2020 | 4.858M |
| June 30, 2020 | 3.339M |
| March 31, 2020 | 1.816M |
| December 31, 2019 | 0.0076M |
| September 30, 2019 | 3.250M |
| June 30, 2019 | -1.372M |
| Date | Value |
|---|---|
| March 31, 2019 | 1.220M |
| December 31, 2018 | 3.111M |
| September 30, 2018 | 6.303M |
| June 30, 2018 | 8.627M |
| March 31, 2018 | 16.32M |
| December 31, 2017 | 17.15M |
| September 30, 2017 | 13.04M |
| June 30, 2017 | 22.85M |
| March 31, 2017 | 22.40M |
| December 31, 2016 | 34.10M |
| September 30, 2016 | 41.04M |
| June 30, 2016 | 40.58M |
| March 31, 2016 | 46.36M |
| December 31, 2015 | 48.72M |
| September 30, 2015 | 41.33M |
| June 30, 2015 | 0.973M |
| March 31, 2015 | 2.595M |
| December 31, 2014 | 2.223M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-6.694M
Minimum
Sep 2024
13.93M
Maximum
Mar 2022
3.294M
Average
3.060M
Median
Shareholders Equity (Quarterly) Benchmarks
| DBV Technologies SA | 54.03M |
| Cellectis SA | 129.42M |
| Adaptimmune Therapeutics PLC | 79.99M |
| Biodexa Pharmaceuticals PLC | 11.04M |
| NuCana PLC | 4.806M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.734M |
| Total Liabilities (Quarterly) | 9.428M |